AHLA

Skip to Main Content

March 22, 2024

Health Law Weekly

Featured Articles

A Conversation on Indigenous Health Equity: Supreme Court to Hear Indian Health Services Reimbursement Cases

Hot Topics in Value-Based Care and the Value-Based Enterprise Rules

Top Considerations for Health Care Board Compensation Committees

Current Topics

Antitrust

Second Circuit Revives Regeneron’s Antitrust Action Against Novartis

Fraud and Compliance

DME Company Owner Sentenced to Nine Years in Prison for Massive Medicare Fraud Scheme

Doctor Sent to Prison for Improperly Distributing Opioids

Eleventh Circuit Upholds Convictions of Addiction Treatment Clinic Owners, Says Government Not Required to Procure Medical Records

Lab Manager Charged in Fraudulent COVID-19 Testing Reimbursement Scheme

Pharmacist Handed over Eight Years in Prison for Controlled Substance Distribution

Pharmacy Operator Pleads Guilty to $36.2 Million Medicare Fraud Scheme

Physician, Staffing Company Agree to $700,000 Settlement of Alleged Kickback Scheme

Podiatrist Convicted in $4 Million Foot Bath Fraud Scheme

Second Circuit Affirms Dismissal of Whistleblower Action Against Pharmacies for Lack of Materiality

U.S. Court in California Rejects Whistleblower Action over Alleged 340B Drug Overcharges

Government Reimbursement

CMS Unveils New ACO Model to Improve Primary Care for Underserved Medicare Beneficiaries

Medicaid Panel Calls for Increasing Transparency of Private Plan Denials, Appeals

MedPAC Issues Report to Congress on Medicare Policy, Payment Updates

Health Care Finance and Transactions

AstraZeneca to Expand Oncology Portfolio with $2 Billion Fusion Pharmaceutical Acquisition

Health Information

OCR Updates Guidance on Online Tracking Technologies

UnitedHealth Says Aid to Providers Tops $2 Billion Following Change Healthcare Cyberattack

Health Policy and Administration

Congress Inks Final Appropriations Deal as Shutdown Deadline Looms

Life Sciences

Bankruptcy Court Confirms Endo Restructuring Plan That Resolves Opioid-Related Claims

FDA Proposes Drug Products, Categories That Would Not Be Eligible for Compounding

Fourth Circuit Asks West Virginia High Court to Weigh in on Public Nuisance Issue in Opioid Lawsuit Against Major Distributors

Reproductive Health Law Hub

Biden Details New Efforts to Advance Women’s Health Research

Current Issue

Health Law Weekly Issue - March 22, 2024